Date | Insider | Price | Amount |
---|---|---|---|
6-20-2023 Insider Buy |
Capital Management LTD. Caissa >10% Owner |
$3.88 CAGR » |
$31,643.69 8,160 shares |
6-9-2023 Insider Buy |
Christopher Ryan Sullivan Chief Financial Officer |
$3.42 CAGR » |
$1,747.62 511 shares |
6-14-2023 Insider Buy |
Capital Management LTD. Caissa >10% Owner |
$3.77 CAGR » |
$63,629.34 16,899 shares |
5-30-2023 Insider Buy |
Capital Management LTD. Caissa >10% Owner |
$2.79 CAGR » |
$7,463.76 2,671 shares |
5-24-2023 Insider Buy |
Capital Management LTD. Caissa >10% Owner |
$2.98 CAGR » |
$26,816.44 9,000 shares |
5-16-2023 Insider Buy |
Capital Management LTD. Caissa >10% Owner |
$2.51 CAGR » |
$11,006.72 4,379 shares |
4-27-2023 Insider Buy |
Capital Management LTD. Caissa >10% Owner |
$2.99 CAGR » |
$22,423.19 7,500 shares |
4-18-2023 Insider Buy |
Capital Management LTD. Caissa >10% Owner |
$2.96 CAGR » |
$73,874.00 25,000 shares |
4-11-2023 Insider Buy |
Capital Management LTD. Caissa >10% Owner |
$2.53 CAGR » |
$142,516.39 56,329 shares |
3-7-2022 Insider Buy |
ARMISTICE CAPITAL, LLC Director and >10% Owner |
$0.67 CAGR » |
$344,132.50 510,000 shares |
1-11-2022 Insider Buy |
ARMISTICE CAPITAL, LLC Director and >10% Owner |
$1.00 CAGR » |
$642,931.32 645,000 shares |
3-14-2022 Insider Buy |
ARMISTICE CAPITAL, LLC Director and >10% Owner |
$0.67 CAGR » |
$151,946.00 226,000 shares |
2-25-2022 Insider Buy |
ARMISTICE CAPITAL, LLC Director and >10% Owner |
$0.80 CAGR » |
$111,806.00 140,000 shares |
2-22-2022 Insider Buy |
ARMISTICE CAPITAL, LLC Director and >10% Owner |
$0.80 CAGR » |
$231,563.50 288,000 shares |
1-20-2022 Insider Buy |
ARMISTICE CAPITAL, LLC Director and >10% Owner |
$0.88 CAGR » |
$274,486.28 312,000 shares |
1-14-2022 Insider Buy |
ARMISTICE CAPITAL, LLC Director and >10% Owner |
$1.00 CAGR » |
$452,767.93 455,000 shares |
1-11-2022 Insider Buy |
ARMISTICE CAPITAL, LLC Director and >10% Owner |
$1.00 CAGR » |
$642,931.32 645,000 shares |
12-10-2021 Insider Buy |
Schond L. Greenway CFO |
$1.57 CAGR » |
$3,502.67 2,231 shares |
9-17-2021 Insider Buy |
ARMISTICE CAPITAL, LLC Director and >10% Owner |
$2.20 CAGR » |
$12,557,901.85 5,700,000 shares |
Also See: Institutional Holders of AVTX
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 06/21/2023 | |
End date: | 04/26/2024 | |
Start price/share: | $960.00 | |
End price/share: | $15.94 | |
Dividends collected/share: | $0.00 | |
Total return: | -98.34% | |
Annualized Gain: | -115.79% | |
Starting investment: | $10,000.00 | |
Ending investment: | $166.00 | |
Years: | 0.85 |
Avalo Therapeutics Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Avalo Therapeutics insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding AVTX
Free AVTX Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the Avalo Therapeutics Insider Buying occurred are:
StarTek Insider Buying |